Singlera Genomics, Yale Partner on NIPT Clinical Trial

Jan 25, 2016

|

NEW YORK (GenomeWeb) – Noninvasive prenatal testing startup Singlera Genomics has partnered on a clinical trial with researchers at Yale University to evaluate Singlera's technology for noninvasive prenatal testing of chromosomal aneuploidy and fetal DNA fraction measurement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Microsoft, But the Brain, Too

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

Been Reclassified

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

This Week in Cell

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

Pursuit of a Cancer Vaccine

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Featured White Papers

DNA quantification and normalization with Promega QuantiFluor dyes on the Application Note Fluent Laboratory Automation Solution

Nucleic acid quantification and normalization by UV measurement on the Application Note Fluent Laboratory Automation Solution

Maxwell HT genomic DNA Extraction From Blood On the Fluent Automation Workstation

The Lifecycle of NGS Samples

Oct

23

Featured Webinar

Perspectives on Small RNA Sequencing: Challenges and Complications of Small RNA Library Prep

This webinar will address a range of methods for optimizing small RNA library preparation.

Oct

25

Featured Webinar

A Comprehensive Strategy for Evaluating NGS Liquid Biopsy and Tumor Tissue Assays

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate NGS oncology assays for genomic tumor profiling of plasma and tissue samples.

Nov

05

Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

Nov

07

Featured Webinar

Implementation of a Comprehensive NGS Oncology Panel including MSI and TMB Signatures

This webinar will provide a first-hand look at how a leading pathology lab implemented a next-generation sequencing panel to capture comprehensive molecular tumor profiles.

Main menu